Literature DB >> 7430175

Avascular necrosis following treatment of congenital dislocation of the hip.

A Kalamchi, G D MacEwen.   

Abstract

A review of 119 patients with congenital dislocation of the hip complicated by avascular necrosis, of whom fifty-one patients were skeletally mature, showed that damage to the physis was very common. Changes in the secondary ossification center (ossific nucleus) alone were found to be of very little value in predicting the nature of the development of the hip, while the change in the proximal femoral physis was the key to predicting residual deformity. The vascular disturbances were classified into four groups depending on the amount of damage involving the ossific nucleus and the physis during treatment of the dislocation. This classification was found to be accurate in predicting the natural history of avascular necrosis. The more severe forms of avascular necrosis were found to be most prevalent in those patients in whom treatment was begun between birth and the age of six months. We also found that preliminary traction and the use of general anesthesia reduced the incidence of the more severe form of avascular necrosis. The functional results found in the skeletally mature patients coincided with the types of vascular changes; the presence of avascular necrosis enhanced the development of arthritis, especially if residual dysplasia and subluxation also were present.

Entities:  

Mesh:

Year:  1980        PMID: 7430175

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  136 in total

Review 1.  Preventive health care, 2001 update: screening and management of developmental dysplasia of the hip in newborns.

Authors:  H Patel
Journal:  CMAJ       Date:  2001-06-12       Impact factor: 8.262

2.  Does Salter innominate osteotomy predispose the patient to acetabular retroversion in adulthood?

Authors:  Daisuke Kobayashi; Shinichi Satsuma; Maki Kinugasa; Ryosuke Kuroda; Masahiro Kurosaka
Journal:  Clin Orthop Relat Res       Date:  2014-11-13       Impact factor: 4.176

3.  Developmental dysplasia of the hip: open reduction as a risk factor for substantial osteonecrosis.

Authors:  G B Firth; A J F Robertson; A Schepers; L Fatti
Journal:  Clin Orthop Relat Res       Date:  2010-06-08       Impact factor: 4.176

4.  Radiological assessment of the effects of splinting on early hip development: results from a randomised controlled trial of abduction splinting vs sonographic surveillance.

Authors:  H M Gardiner; A W Duncan
Journal:  Pediatr Radiol       Date:  1992

5.  Acetabuloplasties at Open Reduction Prevent Acetabular Dysplasia in Intentionally Delayed Developmental Dysplasia of the Hip: A Case-control Study.

Authors:  M Belen Carsi; Nicholas M P Clarke
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

6.  Re-dislocation following open reduction for developmental dysplasia of the hip.

Authors:  Surendra U Kamath; George C Bennet
Journal:  Int Orthop       Date:  2005-04-07       Impact factor: 3.075

7.  Duration of immobilization after developmental dysplasia of the hip and open reduction surgery.

Authors:  Khaled Emara; Mohamed Ahmed Al Kersh; Fahad Abdulazeez Hayyawi
Journal:  Int Orthop       Date:  2018-05-11       Impact factor: 3.075

8.  Prevalence of developmental dysplasia of the hip in children with clubfoot.

Authors:  Daud Ts Chou; Manoj Ramachandran
Journal:  J Child Orthop       Date:  2013-08-30       Impact factor: 1.548

9.  Correlation between avascular necrosis and the presence of the ossific nucleus when treating developmental dysplasia of the hip.

Authors:  Sabit Sllamniku; Cen Bytyqi; Ardiana Murtezani; Emir Q Haxhija
Journal:  J Child Orthop       Date:  2013-10-22       Impact factor: 1.548

10.  Closed reduction and dynamic cast immobilization in patients with developmental dysplasia of the hip between 6 and 24 months of age.

Authors:  YiQiang Li; QingHe Zhou; Yuanzhong Liu; WeiDong Chen; JingChun Li; Federico Canavese; HongWen Xu
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.